美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

百濟神州

230.98

+2.841.24%

盤後：229.75-1.0150-0.44%17:21 EDT

成交量：51.99萬

成交額：1.20億

市值：248.81億

市盈率：-37.72

高：234.15

開：229.30

低：227.40

收：228.14

資料載入中...

總覽公司新聞公告

百濟神州(06160)根據股權計劃發行普通股47.98萬股

百濟神州八年累虧591億日虧2000萬今年營收最高預增40%毛利率80%待考

百濟神州隱藏了一個真相

277億元！A股“醫藥一哥”2024年業績大增55%

百濟神州去年虧損收窄至49.78億預計經營利潤首次為正

【券商聚焦】富瑞維持百濟神州(ONC)“買入”評級指其去年業績強勁

H股跳漲跑贏同行，百濟神州業績有哪些看點？

百濟神州去年收入增長55%至38億美元，百悦澤®銷售額達26億美元

百濟神州發佈2024年報全球總收入38億美元

中国新闻网

百濟神州02月28日繼續上漲，股價創歷史新高

同花顺AI资讯社

百濟神州華麗年報背後，為何不見了吳曉濱？

百濟神州2024年創收超38億美元預計2025年實現經營利潤為正

【大行評級｜瑞銀：上調百濟神州目標價至330美元維持“買入”評級】瑞銀研究報告指，百濟神州去年第四季業績強勁，勝過市場及該行預期。公司為今年全年提供的收入指引為49億美元至53億美元，意味按年增長29%至39%，高過預期。公司亦料今年的經營利潤會收支平衡。基於業績勝預期，該行上調集團今明兩年收入預測各13.2%，下調營銷、一般及行政支出比例2.7個及1.2個百分點，將美股目標價由289.7美元上調至330美元，維持“買入”評級。

2024年我國創新藥市場超1.1萬億元，港股創新藥ETF盤中溢價，百濟神州漲超5%

21世纪经济报道

A股百濟神州一度大漲超9.5%，股價創歷史新高。

百濟神州A股大漲9.7%創歷史新高，去年淨虧同比減至49.8億元。

恒生醫藥ETF重倉股百濟神州績後大漲

每日经济新闻

百濟神州盤中漲逾8% 去年全球總收入同比增長55%

百濟神州開盤大漲超5% 預計2025年實現經營利潤為正

港股異動 | 百濟神州(06160)漲超8% 去年全球總收入同比增長55% 預計2025年實現經營利潤為正

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ONC/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百濟神州","latestPrice":230.98,"timestamp":1744920000000,"preClose":228.14,"halted":0,"volume":519865,"hourTrading":{"tag":"盘后","latestPrice":229.75,"preClose":230.765,"latestTime":"17:21 EDT","volume":54100,"amount":12495855.13,"timestamp":1744924915084},"delay":0,"floatShares":79387510,"shares":107719405,"eps":-6.124009,"marketStatus":"休市中","change":2.84,"latestTime":"04-17 16:00:00 EDT","open":229.3,"high":234.15,"low":227.3961,"amount":119885584.17555,"amplitude":0.029604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.124009,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":228.14,"preHourTrading":{"tag":"盘前","latestPrice":233.81,"preClose":228.14,"latestTime":"08:41 EDT","volume":73,"amount":17065.739250000002,"timestamp":1744893686762},"postHourTrading":{"tag":"盘后","latestPrice":229.75,"preClose":230.765,"latestTime":"17:21 EDT","volume":54100,"amount":12495855.13,"timestamp":1744924915084},"volumeRatio":0.7116059393545304,"impliedVol":0.529,"impliedVolPercentile":0.8767},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":79387510,"roa":"-6.07%","roe":"-18.77%","lyrEps":-6.124009,"volumeRatio":0.7116059393545304,"shares":107719405,"dividePrice":0,"high":234.15,"amplitude":0.029604,"preClose":228.14,"low":227.3961,"week52Low":126.9681,"pbRate":"7.47","psRate":"6.53","week52High":287.88,"institutionHeld":0,"latestPrice":230.98,"eps":-6.124009,"divideRate":0,"volume":519865,"delay":0,"ttmEps":-6.124009,"open":229.3,"prevYearClose":184.71,"prevWeekClose":230.36,"prevMonthClose":272.17,"prevQuarterClose":272.17,"fiveDayClose":208.31,"twentyDayClose":262.59,"sixtyDayClose":222.22,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516852546","title":"百濟神州(06160)根據股權計劃發行普通股47.98萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516852546","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516852546?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 08:15","pubTimestamp":1740960938,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，该公司于2025年2月28日因根据股权计划授出的受限制股份单位获归属(本公司董事除外)而发行普通股47.98万股。于同日，因合资格参与者(公司董事除外)于2025年2月1日至2025年2月28日期间行使购股权而发行普通股合计265.76万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688235","06160","BK1583","BK1161","LU0588546209.SGD","LU0307460666.USD","LU2328871848.SGD","ONC","LU1969619763.USD","BK1588","BK0239","BK1500","BK4139"],"gpt_icon":0},{"id":"2516525294","title":"百濟神州八年累虧591億日虧2000萬 今年營收最高預增40%毛利率80%待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2516525294","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516525294?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 08:12","pubTimestamp":1740960721,"startTime":"0","endTime":"0","summary":"总体来看，近8年来，百济神州净利润累计亏损591.12亿元，日均亏损超过2000万元。对于未来发展，百济神州充满信心，公司预计2025年营业收入约为352亿至381亿元，同比增幅约为29%至40%，预计2025年毛利率将处于80%至90%的中位区间。殷敏涉嫌走私严重影响了百济神州声誉，而上市公司近期也有管理人员离职。资料显示，加入百济神州之前，黄智在2007年至2020年期间就职于诺华。这意味着，百济神州预计2025年营业收入增幅约为29%至40%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303082058a25c2ebb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303082058a25c2ebb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","ONC","06160"],"gpt_icon":0},{"id":"2516517961","title":"百濟神州隱藏了一個真相","url":"https://stock-news.laohu8.com/highlight/detail?id=2516517961","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516517961?lang=zh_tw&edition=fundamental","pubTime":"2025-03-02 20:13","pubTimestamp":1740917580,"startTime":"0","endTime":"0","summary":"　　百济神州在2月27日晚上公布的业绩可以用炸裂来形容。　　不过，百济神州期待中的盈利还是没到来。公司经营性亏损大幅收窄53%到5.68亿美元，而且经调整经营利润已经转正。　　百济自己给出的财务指引是2025年营收50亿美元。　　2024年，泽布替尼在美国的销售额增长了106%，达到19.5亿美元，占据百济神州营收的一半，逐季度的增速平均是20%；欧洲约到美国市场的五分之一。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-02/doc-inenhnuz3227725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","06160","LU1969619763.USD","BK1500","LU2328871848.SGD","LU0307460666.USD","BK1161","BK1588","BK1583","688235","BK0239","LU0588546209.SGD","BK4139"],"gpt_icon":1},{"id":"2516456126","title":"277億元！A股“醫藥一哥”2024年業績大增55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516456126","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516456126?lang=zh_tw&edition=fundamental","pubTime":"2025-03-02 06:03","pubTimestamp":1740866606,"startTime":"0","endTime":"0","summary":"2月27日晚间，百济神州发布2024业绩：Q4营收11亿美元，同比增长78%；全年全球总收入38亿美元，同比增长55%。泽布替尼已在在全球超过70个市场获批，2023年全球销售额达13亿美元，正式跻身“重磅炸弹”药物之列。2024年营收20亿美元，同比增长105%。研发费用研发费用方面，2024年Q4和全年研发支出分别为54万美元，195万美元，均有所增长。目前，百济神州市值达3135亿元，超越恒瑞医药市值3056亿元，成为A股的“医药一哥”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302060507a25a8fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302060507a25a8fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4231","06160","BK4080","BK4139","ADC","688235","ONC"],"gpt_icon":0},{"id":"2516536819","title":"百濟神州去年虧損收窄至49.78億 預計經營利潤首次為正","url":"https://stock-news.laohu8.com/highlight/detail?id=2516536819","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516536819?lang=zh_tw&edition=fundamental","pubTime":"2025-03-01 14:09","pubTimestamp":1740809356,"startTime":"0","endTime":"0","summary":"登陆美股近十年之际，百济神州首次在业绩快报中给出了2025年经营利润为正的预计。其2月28日公布的2024年业绩快报显示，公司在报告期内实现营收272.14亿元，同比增长56.2%，净亏损额也收窄至49.78亿元。两款自研产品BTK抑制剂泽布替尼（商品名为百悦泽）和PD-1肿瘤药替雷利珠单抗（商品名为百泽安）仍是公司营收主力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503013333815476.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503013333815476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","LU0588546209.SGD","BK1583","BK1161","06160","LU0307460666.USD","BK4139","ONC","BK1588","LU1969619763.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514329534","title":"【券商聚焦】富瑞維持百濟神州(ONC)“買入”評級 指其去年業績強勁","url":"https://stock-news.laohu8.com/highlight/detail?id=2514329534","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514329534?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 20:55","pubTimestamp":1740747332,"startTime":"0","endTime":"0","summary":"金吾财讯 | 富瑞发表报告指，百济神州(ONC)去年业绩强劲，尽管投资者对处方数据差异存在讨论，Brukinsa表现依然超出市场预期，第四季收入8.28亿美元，全年收入达26亿美元，按年增105%，净定价保持稳定。公司对2025年提供指引，料全年收入达49亿美元至53亿美元，即按年增29％至39%，并重申2025年达到经营收入收支平衡的目标。该行表示，下一步将关注即将到来的ASCO更新(CDK4、CDK2、B7H4相关进展)。该行将百济神州目标价由286美元上调至308美元，维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/NGY0MmI5YjBmZmE4NTQ4NTQ2MWJlYzY2MzQ2MDk2NDUy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NGY0MmI5YjBmZmE4NTQ4NTQ2MWJlYzY2MzQ2MDk2NDUy.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"285924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","688235","06160"],"gpt_icon":0},{"id":"2516793533","title":"H股跳漲跑贏同行，百濟神州業績有哪些看點？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516793533","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516793533?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 19:51","pubTimestamp":1740743487,"startTime":"0","endTime":"0","summary":"今日早盘港股生物科技板块表现活跃，其中百济神州（06160.HK）表现最为抢眼，一度跳空大涨近8%，此后涨幅回落至3.16%，但表现依然显著强于君实生物（01877.HK）、再鼎医药（09688.HK）、信达生物（01801.HK）等同行。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/1294c2da-f228-42d1-929f-8a8cabdeaef9.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/1294c2da-f228-42d1-929f-8a8cabdeaef9.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67c1a33f23082975a38f607c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1583","BK1161","BK1588","06160","LU0307460666.USD","LU0588546209.SGD","LU2328871848.SGD","LU1969619763.USD","ONC","BK1500","BK4139"],"gpt_icon":0},{"id":"2514344425","title":"百濟神州去年收入增長55%至38億美元，百悦澤®銷售額達26億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514344425","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514344425?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 18:31","pubTimestamp":1740738660,"startTime":"0","endTime":"0","summary":"近日，百济神州公布2024年第四季度和全年财务业绩及业务进展。披露2024年第四季度，全球总收入达11亿美元，同比增长78%，全年全球总收入达38亿美元，同比增长55%；GAAP经营亏损持续收窄，实现全年非GAAP经营利润为正。公司2025年全年收入指引为49亿至53亿美元，同时重申预计GAAP经营利润为正且经营活动产生现金流为正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281832039633d974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281832039633d974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK4139"],"gpt_icon":0},{"id":"2514343462","title":"百濟神州發佈2024年報 全球總收入38億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514343462","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514343462?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 17:09","pubTimestamp":1740733747,"startTime":"0","endTime":"0","summary":"2月27日晚， 百济神州 发布了2024年第四季度及全年的财务业绩，同时发布A股业绩快报公告。财报显示，百济神州2024年在全球市场持续展示出强劲的增长势头，全年总收入达38亿美元，同比增长55%。值得一提的是，百济神州首次给予财务指引，2025年全年总收入指引为49亿至53亿美元，其中包括收入强劲增长的预期，受益于百悦泽?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228172237a257a78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228172237a257a78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK4139","ONC"],"gpt_icon":0},{"id":"2514311411","title":"百濟神州02月28日繼續上漲，股價創歷史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2514311411","media":"同花顺AI资讯社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514311411?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 16:00","pubTimestamp":1740729616,"startTime":"0","endTime":"0","summary":"02月28日，百济神州股价大涨。截至今日收盘，百济神州上涨5.49%，收盘价为238.41元，收盘价创历史新高。百济神州有限公司是一家全球性、商业阶段的生物科技公司，专注于研究、开发、生产以及商业化创新型药物，主要产品百悦泽（（BRUKINSA），BTK抑制剂）、百泽安（抗PD-1单抗）、帕米帕利。近一年公司股价累计上涨85.68%，同期沪深300指数上涨12.75%。根据同花顺问财数据回测分析，前天出现创历史新高的股票，昨天开盘买入平均溢价为1.55%，昨天上涨概率为52.31%；昨天出现创历史新高的股票，今天开盘买入平均溢价为-4.65%，今天上涨概率为14.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160555a25788bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160555a25788bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK0239","06160","688235"],"gpt_icon":0},{"id":"2514313104","title":"百濟神州華麗年報背後，為何不見了吳曉濱？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514313104","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514313104?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 15:18","pubTimestamp":1740727134,"startTime":"0","endTime":"0","summary":"同时，百济神州首次给出财务指引，预计2025年营收为49亿美元至53亿美元，并重申预计在2025年内实现GAAP经营利润为正，且经营活动产生现金流为正。百济神州美股财报截图。另值得一提的是，北京时间2月27日晚的业绩沟通会上，四名高管代表中仅有百济神州高级副总裁、全球研发负责人汪来一位中国面孔，而百济神州全球总裁兼首席运营官吴晓滨则意外缺席。在此前，类似的业绩发布会吴晓滨均会代表公司出席。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228152037a25776c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228152037a25776c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONC"],"gpt_icon":0},{"id":"2514624883","title":"百濟神州2024年創收超38億美元 預計2025年實現經營利潤為正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514624883","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514624883?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 10:40","pubTimestamp":1740710430,"startTime":"0","endTime":"0","summary":"本报讯（记者张敏）2月27日晚间，百济神州有限公司（以下简称“百济神州”）发布了2024年第四季度及全年的财务业绩，同时发布A股业绩快报公告。财报显示，百济神州2024年实现总收入超38亿美元，同比增长55%。产品收入成为推动营收增长的主要动力。具体来看，报告期内，泽布替尼继续在全球市场快速增长，2024年全球销售额总计26亿美元，同比大增105%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502283332829048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","06160","LU0588546209.SGD","ONC","BK1588","BK1583","LU1969619763.USD","BK4139","BK1161","LU2328871848.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2514644713","title":"【大行評級｜瑞銀：上調百濟神州目標價至330美元 維持“買入”評級】瑞銀研究報告指，百濟神州去年第四季業績強勁，勝過市場及該行預期。公司為今年全年提供的收入指引為49億美元至53億美元，意味按年增長29%至39%，高過預期。公司亦料今年的經營利潤會收支平衡。基於業績勝預期，該行上調集團今明兩年收入預測各13.2%，下調營銷、一般及行政支出比例2.7個及1.2個百分點，將美股目標價由289.7美元上調至330美元，維持“買入”評級。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514644713","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514644713?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 10:24","pubTimestamp":1740709492,"startTime":"0","endTime":"0","summary":"瑞银研究报告指，百济神州去年第四季业绩强劲，胜过市场及该行预期。公司为今年全年提供的收入指引为49亿美元至53亿美元，意味按年增长29%至39%，高过预期。公司亦料今年的经营利润会收支平衡。基于业绩胜预期，该行上调集团今明两年收入预测各13.2%，下调营销、一般及行政支出比例2.7个及1.2个百分点，将美股目标价由289.7美元上调至330美元，维持“买入”评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28102448447663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688235","ONC","06160"],"gpt_icon":0},{"id":"2514364535","title":"2024年我國創新藥市場超1.1萬億元，港股創新藥ETF盤中溢價，百濟神州漲超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514364535","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514364535?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 10:06","pubTimestamp":1740708416,"startTime":"0","endTime":"0","summary":"2月28日，港股主要指数低开低走，创新药板块冲高回落。热门ETF中，港股创新药ETF截至发稿下跌0.69%，成交额近5000万元，换手率超10%，开盘后交投活跃。值得注意的是，金融终端最新数据显示，港股创新药ETF年初至今涨幅超20%。资金流向方面，港股创新药ETF连续两日获资金净流入。结合Frost & Sullivan测算初步统计，2024年我国创新药行业市场规模空间超过1.13万亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228101456abe012e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228101456abe012e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588546209.SGD","LU1969619763.USD","06160","BK1574","BK1500","06978","ONC","LU0307460666.USD","BK1161","BK1583","688235","LU2328871848.SGD","BK1588"],"gpt_icon":0},{"id":"2514369133","title":"A股百濟神州一度大漲超9.5%，股價創歷史新高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369133","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514369133?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:58","pubTimestamp":1740707890,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","LU0588546209.SGD","BK1583","LU2328871848.SGD","399300","BK4139","BK1500","ONC","06160","BK0239","LU1969619763.USD","BK1588","BK1161","688235","LU0307460666.USD"],"gpt_icon":0},{"id":"2514289369","title":"百濟神州A股大漲9.7%創歷史新高，去年淨虧同比減至49.8億元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514289369","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514289369?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:57","pubTimestamp":1740707836,"startTime":"0","endTime":"0","summary":"百济神州A股大涨9.7%创历史新高，去年净亏同比减至49.8亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28095748446666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159982","BK1500","BK1588","BK1161","LU0588546209.SGD","688235","LU1969619763.USD","BK1583","ONC","06160","BK4139","LU0307460666.USD","399300","LU2328871848.SGD","BK0239"],"gpt_icon":0},{"id":"2514369090","title":"恒生醫藥ETF重倉股百濟神州績後大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369090","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514369090?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:49","pubTimestamp":1740707356,"startTime":"0","endTime":"0","summary":"2月28日早盘，港股关键指数调整，科技股普调，医药股走势分化，恒生医药ETF（159892）重仓股百济神州一度大涨超7%，微创医疗、微创机器人等跌幅靠前。据百济神州公告，其2024年第四季度全球总收入达11亿美元，同比增长78%，全年全球总收入达38亿美元，同比增长55%；GAAP经营亏损持续收窄，实现全年非GAAP经营利润为正。恒生医药ETF跟踪恒生生物科技指数，指数成分股中，药明生物权重11.55%，百济神州权重11.24%，信达生物权重8.28%，康方生物6.38%，创新属性较强。恒生医药ETF联接（A类：016970，C类：016971）每日经济新闻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095048a2571a02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095048a2571a02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","LU0307460666.USD","BK1161","LU0588546209.SGD","LU1969619763.USD","BK1500","BK1583","688235","06160","BK1588","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514698193","title":"百濟神州盤中漲逾8% 去年全球總收入同比增長55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514698193","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514698193?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:44","pubTimestamp":1740707040,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）盘中涨逾8%，截至发稿，股价上涨5.26%，现报170.10港元，成交额3.18亿港元。\n　　百济神州公布2024年第四季度和全年财务业绩，2024年第四季度，公司全球总收入达11.28亿美元，同比增长78%，经调整经营利润7860.3万美元，同比扭亏为盈；2024年全年，公司全球总收入达38.1亿美元，同比增长55%；经调整经营利润4535.6万美元，同比扭亏为盈；GAAP经营亏损持续收窄，实现全年非GAAP经营利润为正。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-28/doc-inemyxcr5800204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1969619763.USD","ONC","BK1500","LU2328871848.SGD","688235","BK1583","06160","BK1588","BK1161","BK4139","LU0588546209.SGD","LU0307460666.USD","BK0239"],"gpt_icon":0},{"id":"2514389369","title":"百濟神州開盤大漲超5% 預計2025年實現經營利潤為正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389369","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389369?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:39","pubTimestamp":1740706740,"startTime":"0","endTime":"0","summary":"　　2月28日消息，港股百济神州开盘大涨超5%，现报170.4港元，成交额2.82亿港元。　　消息面上，2月27日晚间，百济神州发布了2024年第四季度及全年的财务业绩。财报显示，百济神州2024年在全球市场持续展示出强劲的增长势头，全年总收入达38亿美元，同比增长55%。基于2024年财报业绩表现，百济神州首次给予财务指引，2025年全年总收入指引为49亿至53亿美元，同时，百济神州重申预计GAAP经营利润为正且经营活动产生现金流为正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-02-28/doc-inemyxct2571904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","LU0307460666.USD","BK1161","LU0588546209.SGD","LU1969619763.USD","BK1500","BK1583","688235","06160","BK0239","BK1588","BK4139","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514366363","title":"港股異動 | 百濟神州(06160)漲超8% 去年全球總收入同比增長55% 預計2025年實現經營利潤為正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514366363","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514366363?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:33","pubTimestamp":1740706430,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨超8%，截至发稿，涨8.17%，报174.8港元，成交额2.1亿港元。消息面上，百济神州公布2024年第四季度和全年财务业绩，2024年第四季度，公司全球总收入达11.28亿美元，同比增长78%，经调整经营利润7860.3万美元，同比扭亏为盈；2024年全年，公司全球总收入达38.1亿美元，同比增长55%；经调整经营利润4535.6万美元，同比扭亏为盈；GAAP经营亏损持续收窄，实现全年非GAAP经营利润为正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","688235","LU0588546209.SGD","LU0307460666.USD","LU1969619763.USD","BK0239","BK1583","06160","BK1500","BK1161","BK4139","LU2328871848.SGD","BK1588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.74,"defaultRemindTime":1746604800000,"name":null,"time":"盤前","dateTimestamp":1746590400000,"actualEps":null},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盤前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"盤前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-05-11","symbol":"ONC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715400000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.6818,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6818,"analysts":22,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-04-17","current":-38.113584,"percent":0.422535,"low":-46.072488,"twenty":-42.748137,"median":-33.549429,"eighty":-28.784295,"high":-22.805663,"avg":-34.842528,"sd":7.324243,"marketCap":24575105056},"quantilePoints":[{"date":"2025-01-03","current":-23.85925,"twenty":-23.85925,"median":-23.85925,"eighty":-23.85925,"marketCap":19590153584},{"date":"2025-01-10","current":-23.169003,"twenty":-23.588216,"median":-23.51181,"eighty":-23.096335,"marketCap":18938568040},{"date":"2025-01-17","current":-26.770744,"twenty":-26.217794,"median":-23.689854,"eighty":-23.142836,"marketCap":21882666138},{"date":"2025-01-24","current":-28.798988,"twenty":-27.60701,"median":-25.13119,"eighty":-23.374687,"marketCap":23683664763},{"date":"2025-01-31","current":-29.253094,"twenty":-28.895055,"median":-26.770744,"eighty":-23.516999,"marketCap":24179205805},{"date":"2025-02-07","current":-29.699946,"twenty":-29.114029,"median":-28.456686,"eighty":-23.723733,"marketCap":24422582437},{"date":"2025-02-14","current":-29.279798,"twenty":-29.132261,"median":-28.781271,"eighty":-23.9826,"marketCap":24061904635},{"date":"2025-02-21","current":-31.546239,"twenty":-29.269116,"median":-28.798062,"eighty":-24.917918,"marketCap":26058437677},{"date":"2025-02-28","current":-46.072488,"twenty":-30.312806,"median":-28.916244,"eighty":-26.238043,"marketCap":29706894943},{"date":"2025-03-07","current":-42.702936,"twenty":-33.205878,"median":-29.060335,"eighty":-26.487572,"marketCap":27534255325},{"date":"2025-03-14","current":-42.304107,"twenty":-40.627279,"median":-29.228112,"eighty":-26.926934,"marketCap":27277096074},{"date":"2025-03-21","current":-43.63686,"twenty":-41.989697,"median":-29.279798,"eighty":-27.60701,"marketCap":28136436571},{"date":"2025-03-28","current":-43.795471,"twenty":-42.273573,"median":-29.808923,"eighty":-28.393975,"marketCap":28238706493},{"date":"2025-04-04","current":-44.082326,"twenty":-43.290212,"median":-30.877376,"eighty":-28.597906,"marketCap":28423666794},{"date":"2025-04-11","current":-34.741183,"twenty":-42.946887,"median":-33.164233,"eighty":-28.695114,"marketCap":22400628140},{"date":"2025-04-17","current":-38.113584,"twenty":-42.748137,"median":-33.549429,"eighty":-28.784295,"marketCap":24575105056}],"updateTime":1745134916550}}}